SLC22A3 and chronic obstructive pulmonary disease: Notably, five of the nine drugs predicted to interact with OCT3 at clinically relevant unbound concentrations have warnings and precautions related to cardiovascular side-effects (e.g. cardiac arrhythmia) (Table I, Table SII).